Gripwise® Versus JAMAR®

Completed

• Conditions: Age-Related Sarcopenia

• Registration Number: NCT05060874
• Lead Sponsor: University Hospital, Caen

Brief Summary

It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement.

Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones.

This cross-sectional study will include 348 patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-09-01
• Primary Completion: 2021-09-01
• Study First Submitted: 2021-09-22
• Study First Submitted QC: 2021-09-22
• Study First Posted: 2021-09-29
• Status Verified: 2021-11
• Study Completion: 2021-11-18
• Last Update Submitted: 2021-11-18
• Last Update Posted: 2021-11-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 348

Inclusion Criteria

• men and women aged 65 or over
• affiliated to a health insurance
• Francophone.

Exclusion Criteria

• • refusal to participate
• unable to communicate
• unable to use both hands (dominant and non-dominant)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison between Jamar® and Gripwise® values for grip strength measurement	day1	Intra-class correlation between the best values obtained with each device

Secondary Outcome Measures

Name	Time	Method
satisfaction using the devices	day1	rate of patients finding one of both device easier to use
factors influencing detected weakness	day1	significant difference in the rate of women detected as weak with a handgrip \<16kg and men \<27kg, between the different reasons for hospitalisation, the number of days of hospitalisation, and between the different chronic cancerous and non-cancerous pathologies (Updated Charlson Comorbidity Index), the age groups 65-79 years and ≥80 years
comparison according to the patient's position	day1	correlations of dynamometer measurements between patients assessed in the sitting or lying position
number of attempt to reach the maximum value	day1	Comparison of the three measurements obtained for each patient with each device

Trial Locations

Locations (1)

Caen University Hospital; 🇫🇷 Caen, France